Effects of dexamethasone on immune dysfunction and ventilator-associated pneumonia in COVID-19 acute respiratory distress syndrome: an observational study

Dexamethasone improves survival of patients with COVID-19 acute respiratory distress syndrome, but might shorten the delay between the start of invasive mechanical ventilation and the occurrence of ventilator-associated pneumonia, suggesting possible worsening of COVID-19-induced immune dysfunction...

Descripción completa

Detalles Bibliográficos
Autores principales: Cour, Martin, Simon, Marie, Argaud, Laurent, Monneret, Guillaume, Venet, Fabienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522132/
https://www.ncbi.nlm.nih.gov/pubmed/34663481
http://dx.doi.org/10.1186/s40560-021-00580-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522132/
https://www.ncbi.nlm.nih.gov/pubmed/34663481
http://dx.doi.org/10.1186/s40560-021-00580-6

Ejemplares similares